Business Wire

Western Union Continues to Connect Communities and Economies at a Critical Time

25.6.2020 15:00:00 EEST | Business Wire | Press release

Share

Western Union (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today released its second annual Environmental, Social and Governance (ESG) Report, which spotlights the Company’s 2019 ESG progress. The report also highlights Western Union’s response and ongoing initiatives surrounding the COVID-19 pandemic and social justice movements across the globe in early 2020.

“Today, against the backdrop of COVID-19 and global protests against social injustice, business’s role in building a more united future has never seemed more relevant – or more urgent. Serving our stakeholders in today’s world takes determination and innovation. It demands that we build unity through ingenuity to create new, lasting solutions for people, businesses, and societies,” said Hikmet Ersek, President and CEO, Western Union. “This report provides an update on Western Union’s ESG efforts, and how we are addressing some of the most pressing global issues facing society, our shared environment, and our Company.”

The report highlights six key areas where Western Union is making an impact globally:

Connecting people and businesses to the global economy: Our services connect people and businesses pursuing global opportunities – for example, individuals looking to better the lives of their families, and businesses looking for new partners, customers, and markets. The transactions we process build bridges across economies, geographies, and cultures.

  • In response to COVID-19, Western Union doubled down on its commitment to serve customers with a range of new offerings and resources including piloting home delivery of money transfers, introducing “digital location” concierge services to offer personalized phone or video support to help customers make digital money transfers, expanding westernunion.com to five additional countries bringing the total to more than 75, and expanding real-time account and wallet payout to 50 countries.

Fostering an engaging and inclusive workplace: Western Union works to build and support a workforce that reflects the global diversity of the 150 million customers we serve in more than 200 countries and territories around the world. It starts at the most senior levels of our business and manifests itself throughout our Board of Directors and our global workforce. We are actively engaging in open and honest dialogue with our employees and we are committed to playing a role in the fight for positive change globally. 2019 highlights include:

  • Reaching gender parity with our customers and employees: approximately half of our customers and half of our global workforce are women.
  • Our executive team in 2019 was comprised of 40% women and includes leaders born in 10 different countries who have wide-ranging global leadership experience.

Moving money with integrity: We are committed to using the right combination of people and technology to protect our customers and partners, keep illicit activity out of our network, and ensure we conduct our business with integrity.

  • In 2019, we prevented $1.1 billion in fraudulent transactions. Overall industry data suggests a growing rate of fraudulent activity. Western Union’s fraud levels, however, are trending downward.
  • Our Financial Intelligence Unit continues to partner with law enforcement and nonprofit entities to better target and disrupt human trafficking financial flows. This team has conducted approximately 1,800 human trafficking investigations since 2013, resulting in hundreds of arrests and the rescue of hundreds of victims.

Governing and managing for success: Western Union’s governance structures and practices provide oversight and guidance around critical issues, including ethics, board diversity, executive compensation, fair competition, data privacy, and cybersecurity, and board diversity. 2019 highlights include:

  • Our Board is comprised of a wide range of nationalities from around the world.
  • Three of our 11 Board members were women.

Safeguarding our shared environment: We are committed to acting responsibly to respect the environment and minimize our footprint.

  • 25% of building materials, by value, are made of recycled materials at our global headquarters.
  • We have equipped our major offices with state-of-the-art video conferencing technology, which reduced the need for air travel between locations, even prior to COVID-19.

Catalyzing change through the Western Union Foundation: The Western Union Foundation works to provide vulnerable youth with the skills needed to succeed in today’s global digital economy, and to support people across the globe through humanitarian relief.

  • In 2019, the Western Union Foundation launched Opportunity Beyond Borders, a three-year and $15-million commitment to provide vulnerable youth with the skills and training needed to succeed in today’s global digital economy.
  • As the impact of COVID-19 spread across the globe, Western Union and the Western Union Foundation announced a global matching challenge, with a total commitment of $1.3 million in customer, corporate, employee, and agent donations towards the global fight against the virus.

The Western Union 2019 ESG Report is available at: http://ir.westernunion.com/investor-relations/ESG/default.aspx. It is prepared in accordance with the Global Reporting Initiative (GRI) standards, and also includes responses to select relevant metrics from the Sustainability Accounting Standards Board (SASB) Standards.

WU-G

About Western Union

The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Our omnichannel platform connects the digital and physical worlds and makes it possible for consumers and businesses to send and receive money and make payments with speed, ease, and reliability. As of March 31, 2020, our network included over 550,000 retail agent locations offering our branded services in more than 200 countries and territories, with the capability to send money to billions of accounts. Additionally, westernunion.com, our fastest growing channel in 2019, is available in over 75 countries, plus additional territories, to move money around the world. With our global reach, Western Union moves money for better, connecting family, friends, and businesses to enable financial inclusion and support economic growth. For more information, visit www.westernunion.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Western Union Contacts

Investor Relations:
Brendan Metrano; Brendan.metrano@wu.com
+1(720) 332-8089

Media Relations:
Western Union Global Communications
Rachel Rogala; Rachel.Rogala@wu.com
+ 1 (303) 808-2674

Pia De Lima; Pia.DeLima@wu.com
+1 (954) 260-5732

Western Union Americas
Margaret Fogarty; Margaret.Fogarty@wu.com

Western Union Middle East & Africa
Mohamed El Khalouki; Mohamed.ElKhalouki@wu.com

Western Union Asia-Pacific
Karen Santos; Karen.Santos2@wu.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 13:38:00 EEST | Press release

For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will

Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 12:48:00 EEST | Press release

Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye